The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, has demonstrated the safety of treatment with the molecule AEF0217, developed by the French biotech Aelis Farma, as well as its effectiveness in improving cognitive function in these people.
Life expectancy in India suffered large and unequal declines during COVID-19 pandemic
The international study, co-authored by the Department of Sociology and the Leverhulme Centre for Demographic Science’s Dr Aashish Gupta and Professor Ridhi Kashyap, reveals that